ID   WAe009-A-2B
AC   CVCL_E4DD
SY   H9-ID1/ID3 KO-#2; BTHBIOe010-A-2B
DR   BioSamples; SAMEA115547969
DR   hPSCreg; WAe009-A-2B
RX   PubMed=39342788;
CC   From: Beijing Institute of Ophthalmology, Beijing Tongren Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5360; ID1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5362; ID3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=39342788
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 15,19
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 12.3,13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D6S1043: 12,19
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=39342788; DOI=10.1016/j.scr.2024.103569;
RA   Li Y.-H., Du M.-X., Jin Z.-B.;
RT   "Generation of ID1/3 knockout human embryonic stem cell lines
RT   (WAe009-A-2A and WAe009-A-2B) derived from H9 using CRISPR/Cas9.";
RL   Stem Cell Res. 81:103569-103569(2024).
//